Were David Cordani’s Cigna Group (CI) share sales discretionary or pre-planned?

The filing states the transactions were effected under a Rule 10b5-1 trading plan adopted on February 6, 2026. Such plans are established in advance, so the timing of these sales reflects a pre-arranged schedule rather than day-to-day discretionary trading decisions.

What is David Cordani’s direct Cigna Group (CI) share ownership after these transactions?

After completing the reported option exercises and share sales, Cordani directly held 57,766 shares of Cigna Group common stock. The filing also notes additional indirect holdings through a 401(k) plan, a trust, and a GRAT, which are reported separately from his direct ownership.

Cigna Group (CI) CEO sells 201,878 shares after major option exercises

Filing Impact

(Very High)

Filing Sentiment

(Very Negative)

Form Type

Rhea-AI Filing Summary

The Cigna Group’s Chairman and CEO David Cordani exercised employee stock options and sold shares in a pre-planned series of transactions. On May 12–13, 2026, he exercised options covering 212,543 shares of common stock at exercise prices of $149.135 and $197.35 per share, converting them into common shares.

Over the same period, he conducted open-market sales totaling 201,878 shares of common stock at weighted average prices generally between about $286 and $299 per share, according to price ranges in the filing. These sales were made under a Rule 10b5-1 trading plan adopted on February 6, 2026, meaning they were pre-arranged rather than opportunistic.

After these transactions, Cordani directly owned 57,766 shares of Cigna Group common stock. The filing also lists additional indirect holdings, including shares held through a 401(k) plan, a trust, and a GRAT, which are separate from his direct position.

Insider Trade Summary 10b5-1

Net Seller: 201,878 shares ($59,114,186)

Net Sell 24 txns

Insider Cordani David

Role Chairman & CEO

Sold 201,878 shs ($59.11M)

Type	Security	Shares	Price	Value
Exercise	Employee Stock Option (Right to Buy)	15,458	$0.00	--
Exercise	Employee Stock Option (Right to Buy)	7,971	$0.00	--
Exercise	Common Stock, $.01 Par Value	15,458	$149.135	$2.31M
Exercise	Common Stock, $.01 Par Value	7,971	$197.35	$1.57M
Exercise	Employee Stock Option (Right to Buy)	103,595	$0.00	--
Exercise	Employee Stock Option (Right to Buy)	85,519	$0.00	--
Exercise	Common Stock, $.01 Par Value	103,595	$149.135	$15.45M
Exercise	Common Stock, $.01 Par Value	85,519	$197.35	$16.88M
Sale	Common Stock, $.01 Par Value	3,903	$286.832	$1.12M
Sale	Common Stock, $.01 Par Value	14,292	$287.9646	$4.12M
Sale	Common Stock, $.01 Par Value	13,839	$288.8544	$4.00M
Sale	Common Stock, $.01 Par Value	41,099	$290.0018	$11.92M
Sale	Common Stock, $.01 Par Value	13,732	$291.0056	$4.00M
Sale	Common Stock, $.01 Par Value	12,315	$291.9459	$3.60M
Sale	Common Stock, $.01 Par Value	7,861	$292.8776	$2.30M
Sale	Common Stock, $.01 Par Value	2,142	$293.919	$630K
Sale	Common Stock, $.01 Par Value	38,487	$294.9798	$11.35M
Sale	Common Stock, $.01 Par Value	34,641	$295.9844	$10.25M
Sale	Common Stock, $.01 Par Value	2,017	$296.8357	$599K
Sale	Common Stock, $.01 Par Value	15,319	$298.2398	$4.57M
Sale	Common Stock, $.01 Par Value	2,231	$298.5328	$666K
holding	Common Stock, $.01 Par Value	--	--	--
holding	Common Stock, $.01 Par Value	--	--	--
holding	Common Stock, $.01 Par Value	--	--	--

Holdings After Transaction: Employee Stock Option (Right to Buy) — 0 shares (Direct, null); Common Stock, $.01 Par Value — 49,795 shares (Direct, null); Common Stock, $.01 Par Value — 440,798 shares (Indirect, By GRAT)

Footnotes (1)

These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. Represents the weighted average price of the shares sold. The prices actually received ranged from $286.43 to $287.425 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range. Represents the weighted average price of the shares sold. The prices actually received ranged from $287.43 to $288.42 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range. Represents the weighted average price of the shares sold. The prices actually received ranged from $288.435 to $289.41 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range. Represents the weighted average price of the shares sold. The prices actually received ranged from $289.435 to $290.43 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range. Represents the weighted average price of the shares sold. The prices actually received ranged from $290.44 to $291.438 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range. Represents the weighted average price of the shares sold. The prices actually received ranged from $291.44 to $292.435 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range. Represents the weighted average price of the shares sold. The prices actually received ranged from $292.44 to $293.435 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range. Represents the weighted average price of the shares sold. The prices actually received ranged from $293.46 to $294.45 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range. Represents the weighted average price of the shares sold. The prices actually received ranged from $294.46 to $295.453 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range. Represents the weighted average price of the shares sold. The prices actually received ranged from $295.46 to $296.45 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range. Represents the weighted average price of the shares sold. The prices actually received ranged from $296.46 to $297.45 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range. Represents the weighted average price of the shares sold. The prices actually received ranged from $297.492 to $298.49 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range. Represents the weighted average price of the shares sold. The prices actually received ranged from $298.495 to $298.675 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range. Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan. This option was granted on February 28, 2017. The option vested in three equal annual installments starting on March 1, 2018. This option was granted on February 28, 2018. The option vested in three equal annual installments starting on March 1, 2019.

Key Figures

Shares sold: 201,878 shares Options exercised: 212,543 shares Strike price 1: $149.135 per share +5 more

8 metrics

Shares sold 201,878 shares Total open-market sales of common stock reported in Form 4

Options exercised 212,543 shares Total shares underlying employee stock options exercised

Strike price 1 $149.135 per share Exercise price for one employee stock option grant

Strike price 2 $197.35 per share Exercise price for another employee stock option grant

Direct holdings after transactions 57,766 shares Directly owned Cigna common shares following reported trades

Rule 10b5-1 plan adoption date February 6, 2026 Date CEO adopted the trading plan governing these sales

GRAT indirect holdings 440,798 shares Common stock held indirectly by a GRAT associated with Cordani

Trust indirect holdings 157,935 shares Common stock held indirectly by a trust associated with Cordani

Key Terms

Rule 10b5-1 trading plan, Employee Stock Option (Right to Buy), weighted average price, 401(k) Plan, +2 more

6 terms

Rule 10b5-1 trading plan regulatory

"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

Employee Stock Option (Right to Buy) financial

"security_title: "Employee Stock Option (Right to Buy)" with underlying common stock shares."

weighted average price financial

"Represents the weighted average price of the shares sold. The prices actually received ranged from $286.43 to $287.425 per share."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

401(k) Plan financial

"Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan."

A 401(k) plan is a workplace retirement account that lets employees set aside part of their pay into a tax-advantaged savings pot, often with employers adding matching contributions — like a workplace piggy bank for future income. It matters to investors because the amount people save and how employers fund these plans influence consumer spending, corporate payroll costs and the flow of money into financial markets, which can affect stock prices and company valuations.

GRAT financial

"Common Stock, $.01 Par Value ... nature_of_ownership: "By GRAT" in an indirect holding entry."

open-market sale financial

"transaction_action: "open-market sale" for multiple common stock transactions on May 12, 2026."

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Form 4 Insider Transactions: What Each Field Means →

05/14/2026 - 04:47 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cordani David

(Last)

(First)

(Middle)

900 COTTAGE GROVE ROAD

(Street)

BLOOMFIELD

CONNECTICUT

06002

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Cigna Group [ CI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chairman & CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, $.01 Par Value	05/12/2026		M⁽¹⁾		103,595	A	$149.135	150,696	D
Common Stock, $.01 Par Value	05/12/2026		M⁽¹⁾		85,519	A	$197.35	236,215	D
Common Stock, $.01 Par Value	05/12/2026		S⁽¹⁾		3,903	D	$286.832⁽²⁾	232,312	D
Common Stock, $.01 Par Value	05/12/2026		S⁽¹⁾		14,292	D	$287.9646⁽³⁾	218,020	D
Common Stock, $.01 Par Value	05/12/2026		S⁽¹⁾		13,839	D	$288.8544⁽⁴⁾	204,181	D
Common Stock, $.01 Par Value	05/12/2026		S⁽¹⁾		41,099	D	$290.0018⁽⁵⁾	163,082	D
Common Stock, $.01 Par Value	05/12/2026		S⁽¹⁾		13,732	D	$291.0056⁽⁶⁾	149,350	D
Common Stock, $.01 Par Value	05/12/2026		S⁽¹⁾		12,315	D	$291.9459⁽⁷⁾	137,035	D
Common Stock, $.01 Par Value	05/12/2026		S⁽¹⁾		7,861	D	$292.8776⁽⁸⁾	129,174	D
Common Stock, $.01 Par Value	05/12/2026		S⁽¹⁾		2,142	D	$293.919⁽⁹⁾	127,032	D
Common Stock, $.01 Par Value	05/12/2026		S⁽¹⁾		38,487	D	$294.9798⁽¹⁰⁾	88,545	D
Common Stock, $.01 Par Value	05/12/2026		S⁽¹⁾		34,641	D	$295.9844⁽¹¹⁾	53,904	D
Common Stock, $.01 Par Value	05/12/2026		S⁽¹⁾		2,017	D	$296.8357⁽¹²⁾	51,887	D
Common Stock, $.01 Par Value	05/12/2026		S⁽¹⁾		15,319	D	$298.2398⁽¹³⁾	36,568	D
Common Stock, $.01 Par Value	05/12/2026		S⁽¹⁾		2,231	D	$298.5328⁽¹⁴⁾	34,337	D
Common Stock, $.01 Par Value	05/13/2026		M⁽¹⁾		15,458	A	$149.135	49,795	D
Common Stock, $.01 Par Value	05/13/2026		M⁽¹⁾		7,971	A	$197.35	57,766	D
Common Stock, $.01 Par Value								440,798	I	By GRAT
Common Stock, $.01 Par Value								157,935	I	By Trust
Common Stock, $.01 Par Value								1,803.1422⁽¹⁵⁾	I	By 401(k)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Employee Stock Option (Right to Buy)	$149.135	05/12/2026		M⁽¹⁾			103,595⁽¹⁶⁾	03/01/2018	02/28/2027	Common Stock, $.01 Par Value	103,595	$0	15,458	D
Employee Stock Option (Right to Buy)	$149.135	05/13/2026		M⁽¹⁾			15,458⁽¹⁶⁾	03/01/2018	02/28/2027	Common Stock, $.01 Par Value	15,458	$0	0	D
Employee Stock Option (Right to Buy)	$197.35	05/12/2026		M⁽¹⁾			85,519⁽¹⁷⁾	03/01/2019	02/28/2028	Common Stock, $.01 Par Value	85,519	$0	7,971	D
Employee Stock Option (Right to Buy)	$197.35	05/13/2026		M⁽¹⁾			7,971⁽¹⁷⁾	03/01/2019	02/28/2028	Common Stock, $.01 Par Value	7,971	$0	0	D

Explanation of Responses:

1. These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

2. Represents the weighted average price of the shares sold. The prices actually received ranged from $286.43 to $287.425 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

3. Represents the weighted average price of the shares sold. The prices actually received ranged from $287.43 to $288.42 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

4. Represents the weighted average price of the shares sold. The prices actually received ranged from $288.435 to $289.41 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

5. Represents the weighted average price of the shares sold. The prices actually received ranged from $289.435 to $290.43 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

6. Represents the weighted average price of the shares sold. The prices actually received ranged from $290.44 to $291.438 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

7. Represents the weighted average price of the shares sold. The prices actually received ranged from $291.44 to $292.435 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

8. Represents the weighted average price of the shares sold. The prices actually received ranged from $292.44 to $293.435 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

9. Represents the weighted average price of the shares sold. The prices actually received ranged from $293.46 to $294.45 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

10. Represents the weighted average price of the shares sold. The prices actually received ranged from $294.46 to $295.453 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

11. Represents the weighted average price of the shares sold. The prices actually received ranged from $295.46 to $296.45 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

12. Represents the weighted average price of the shares sold. The prices actually received ranged from $296.46 to $297.45 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

13. Represents the weighted average price of the shares sold. The prices actually received ranged from $297.492 to $298.49 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

14. Represents the weighted average price of the shares sold. The prices actually received ranged from $298.495 to $298.675 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

15. Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan.

16. This option was granted on February 28, 2017. The option vested in three equal annual installments starting on March 1, 2018.

17. This option was granted on February 28, 2018. The option vested in three equal annual installments starting on March 1, 2019.

Remarks:

Exhibit 24 - Power of Attorney

	Tyler Gratton, attorney-in-fact	05/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Cigna Group (CI) CEO David Cordani do in this Form 4 filing?

David Cordani exercised employee stock options and sold Cigna Group common shares. He exercised options for 212,543 shares, then sold 201,878 shares in open-market transactions, all executed under a pre-arranged Rule 10b5-1 trading plan adopted earlier in 2026.

How many Cigna Group (CI) shares did David Cordani sell and at what prices?

Cordani sold 201,878 Cigna Group common shares in multiple open-market trades. The filing reports weighted average sale prices, with actual prices falling across several ranges between about $286.43 and $298.675 per share, detailed in a series of price-range footnotes.

How many Cigna Group (CI) options did David Cordani exercise and at what strike prices?

He exercised employee stock options covering 212,543 shares of Cigna common stock. These options had exercise prices of $149.135 and $197.35 per share and were originally granted in 2017 and 2018, vesting in three equal annual installments beginning the following March.

What indirect Cigna Group (CI) holdings for David Cordani are disclosed in the Form 4?

The Form 4 lists indirect ownership entries for common shares held by a 401(k) plan, a trust, and a GRAT associated with Cordani. These entries show separate share balances for each vehicle, indicating additional economic exposure beyond his directly held 57,766 common shares.